Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colorectal Carcinoma (CRC) Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT04392479
What this trial is testing

TWICE-IRI: Optimization of Second-line Therapy With Aflibercept, Irinotecan (Day 1 or Day 1,3), 5-Fluorouracile and Folinic Acid in Patients With Metastatic Colorectal Cancer. A Randomized Phase III Study.

Who this might be right for
Cancer ColorectalMetastasis
Hôpital Franco-Britannique-Fondation Cognacq-Jay 202
Not applicableStudy completedNCT04762914
What this trial is testing

Observing the Perioperative Effects of Prehabilitation in Colorectal Cancer Patients

Who this might be right for
Colon Cancer
Medway Primary Care Trust 52
Large-scale testing (Phase 3)Study completedNCT00296608
What this trial is testing

Radiation Therapy With or Without Chemotherapy Before Surgery in Treating Patients With Stage II or Stage III Rectal Cancer

Who this might be right for
Colorectal Cancer
Federation Francophone de Cancerologie Digestive 762
Testing effectiveness (Phase 2)Study completedNCT00006050
What this trial is testing

Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
UNICANCER
Not applicableLooking for participantsNCT06174233
What this trial is testing

The French Gut-colo

Who this might be right for
Patients Aged 50-75 and Requiring Colonoscopy
Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement 2,500
Testing effectiveness (Phase 2)Study completedNCT00444678
What this trial is testing

Cetuximab Plus Biweekly Capecitabine and Oxaliplatin in KRAS Wild Type Metastatic Colorectal Cancer

Who this might be right for
Colorectal CancerNeoplasm Metastasis
NYU Langone Health 36
Early research (Phase 1)Ended earlyNCT01212887
What this trial is testing

Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer

Who this might be right for
Breast CancerColorectal CancerGastric Cancer+4 more
Cancer Research UK 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT03796884
What this trial is testing

Linaclotide in Treating Patients With Stages 0-3 Colorectal Cancer

Who this might be right for
Colorectal AdenomaStage 0 Colorectal Cancer AJCC v8Stage I Colorectal Cancer AJCC v8+8 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 150
Testing effectiveness (Phase 2)Study completedNCT00002933
What this trial is testing

Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer

Who this might be right for
Colorectal Cancer
Case Comprehensive Cancer Center 21
Testing effectiveness (Phase 2)Study completedNCT03559543
What this trial is testing

Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma

Who this might be right for
Colorectal NeoplasmIntestinal NeoplasmsGastrointestinal Neoplasms+6 more
Catalysis SL 40
Testing effectiveness (Phase 2)UnknownNCT03831698
What this trial is testing

Omega 3 Fatty Acids in Colorectal Cancer (CRC) Prevention in Patients With Lynch Syndrome (COLYNE)

Who this might be right for
Colorectal CancerLynch Syndrome
University of Kansas Medical Center 21
Not applicableWithdrawnNCT01012804
What this trial is testing

Study of Biomarkers in Tissue Samples From Patients With Metastatic Colon Cancer

Who this might be right for
Colorectal Cancer
Georgetown University
Testing effectiveness (Phase 2)Study completedNCT00044343
What this trial is testing

GW572016, An Oral Drug For Colorectal Cancer Patients Having Prior Therapy With 5-FU Plus CPT-11 And/Or Oxaliplatin

Who this might be right for
Colorectal Cancer
GlaxoSmithKline 80
Not applicableWithdrawnNCT04285008
What this trial is testing

Randomized Controlled Study Comparing Colon Evaluation With The Pure-Vu System To A Standard Colonoscopy In Patients Who Are High Risk For Inadequate Bowel Preparation

Who this might be right for
Gastrointestinal DiseaseColorectal Cancer
Motus GI Medical Technologies Ltd
Early research (Phase 1)WithdrawnNCT02573220
What this trial is testing

Irinotecan Hydrochloride With FOLFIRI and Cetuximab as First-Line Therapy in Treating Patients With RAS Wild-Type Colorectal Cancer

Who this might be right for
Stage IVA Colorectal CancerStage IVB Colorectal Cancer
University of Chicago
Testing effectiveness (Phase 2)Active Not RecruitingNCT05677113
What this trial is testing

QBECO Versus Placebo in the Treatment of Colorectal Cancer That Has Spread to the Liver

Who this might be right for
Colorectal CancerLiver Metastases
Sunnybrook Health Sciences Centre 115
Post-approval studies (Phase 4)Ended earlyNCT01468623
What this trial is testing

Study Comparing Optimized 5-FU Dosing and Standard Dosing in Metastatic Colorectal Cancer Patients Treated With mFOLFOX6

Who this might be right for
Colorectal Cancer, Metastatic
Myriad Genetic Laboratories, Inc. 51
Not applicableWithdrawnNCT02422680
What this trial is testing

Patient Satisfaction With Colonoscopy in a Danish Setting - What Are the Most Important Factors?

Who this might be right for
Colorectal Cancer
Aalborg University Hospital
Testing effectiveness (Phase 2)Study completedNCT00063960
What this trial is testing

Hepatic Arterial Infusion With Floxuridine and Systemic Irinotecan After Surgery in Treating Patients With Hepatic (Liver) Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Alliance for Clinical Trials in Oncology 94
Testing effectiveness (Phase 2)Study completedNCT00041808
What this trial is testing

Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver

Who this might be right for
Metastases, NeoplasmColorectal NeoplasmsEsophageal Neoplasms+9 more
FeRx 20
Next Page